Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Protein delivery using engineered virus-like particles
  2. Kaczmarczyk, S. J.; Sitaraman, K.; Young, H. A.; Hughes, S. H.; Chatterjee, D. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Oct; 108(41): 16998-17003.
  1. 2.   Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy
  2. Barsov, E. V.
  3. Immunotherapy. 2011, Mar; 3(3): 407-421.
  1. 3.   Transduction of rhesus macaque hematopoietic stem and progenitor cells with avian sarcoma and leukosis viral vectors
  2. Hu, J. Q.; Ferris, A.; Larochelle, A.; Krouse, A. E.; Metzger, M. E.; Donahue, R. E.; Hughes, S. H.; Dunbar, C. E.
  3. Human Gene Therapy. 2007, Aug; 18(8): 691-700.
  1. 4.   Efficiency of human immunodeficiency virus type 1 postentry infection processes: Evidence against disproportionate numbers of defective virions
  2. Thomas, J. A.; Ott, D. E.; Gorelick, R. J.
  3. Journal of Virology. 2007, Apr; 81(8): 4367-4370.
  1. 5.   Avian sarcoma leukosis virus (ASLV) derived retroviral vectors efficiently transduce CD34+cells and have a distinct integration profile in the rhesus macaque transplantation model
  2. Hu, J. Q.; Ferris, A.; Hughes, S.; Dunbar, C. E.
  3. Blood. 2005, NOV 16; 106(11, Part 1): 375A, Abstract 1290-375A, Abstract 1290.
  1. 6.   Alternate polypurine tracts (PPTs) affect the Rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction
  2. Chang, K. W.; Julias, J. G.; Alvord, W. G.; Oh, J.; Hughes, S. H.
  3. Journal of Virology. 2005, NOV; 79(21): 13694-13704.
  1. 7.   Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells
  2. Calmels, B.; Ferguson, C.; Laukkanen, M. O.; Adler, R.; Faulhaber, M.; Kim, H. J.; Sellers, S.; Hematti, P.; Schmidt, M.; von Kalle, C.; Akagi, K.; Donahue, R. E.; Dunbar, C. E.
  3. Blood. 2005, OCT 1; 106(7): 2530-2533.
  1. 8.   IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development
  2. Leeanansaksiri, W.; Wang, H.; Gooya, J. M.; Renn, K.; Abshari, M.; Tsai, S.; Keller, J. R.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 7014-7021.
  1. 9.   Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials
  2. Yang, Q. E.; Fong, S. E.; Li, K. G.; Gonda, M. A.; Tobin, G. J.
  3. Medical Science Monitor. 2005, JUN; 11(6): BR154-BR161.
  1. 10.   Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase Stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation
  2. Rulli, K.; Yugawa, T.; Hanson, C.; Thompson, D.; Ruscetti, S.; Nishigaki, K.
  3. Journal of Virology. 2004 78(9): 4573-4581.
  1. 11.   High rates of human immunodeficiency virus type I recombination: Near-random segregation of markers one kilobase apart in one round of viral replication
  2. Rhodes, T.; Wargo, H.; Hu, W. S.
  3. Journal of Virology. 2003 77(20): 11193-11200.
  1. 12.   Inserting a nuclear targeting signal into a replication- competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection
  2. Seamon, J. A.; Jones, K. S.; Miller, C.; Roth, M. J.
  3. Journal of Virology. 2002 76(16): 8475-8484.
  1. 13.   Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: Identification by a subtractive screen of novel uniparental fibroblast lines
  2. Piras, G.; El Kharroubi, A.; Kozlov, S.; Escalante-Alcalde, D.; Hernandez, L.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Stewart, C. L.
  3. Molecular and Cellular Biology. 2000 20(9): 3308-3315.
  1. 14.   Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching
  2. Svarovskaia, E. S.; Delviks, K. A.; Hwang, C. K.; Pathak, V. K.
  3. Journal of Virology. 2000 74(15): 7171-7178.
  1. 15.   Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity
  2. Halvas, E. K.; Svarovskaia, E. S.; Pathak, V. K.
  3. Journal of Virology. 2000 74(1): 312-319.
  1. 16.   An avian sarcoma leukosis virus-based gene trap vector for mammalian cells
  2. Zheng, X. Q. H.; Hughes, S. H.
  3. Journal of Virology. 1999 73(8): 6946-6952.
  1. 17.   Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens
  2. Smith, J. S.; Keller, J. R.; Lohrey, N. C.; McCauslin, C. S.; Ortiz, M.; Cowan, K.; Spence, S. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(16): 8855-8860.
  1. 18.   Spontaneous and Ligand-Induced Trafficking of Cxc-Chemokine Receptor 4
  2. Tarasova, N. I.; Stauber, R. H.; Michejda, C. J.
  3. Journal of Biological Chemistry. 1998 273(26): 15883-15886.
  1. 19.   The Ev-O-Derived Cell Line Df-1 Supports the Efficient Replication of Avian Leukosis-Sarcoma Viruses and Vectors
  2. Schaeferklein, J.; Givol, I.; Barsov, E. V.; Whitcomb, J. M.; Vanbrocklin, M.; Foster, D. N.; Federspiel, M. J.; Hughes, S. H.
  3. Virology. 1998 248(2): 305-311.
  1. 20.   Development and Applications of Enhanced Green Fluorescent Protein Mutants
  2. Stauber, R. H.; Horie, K.; Carney, P.; Hudson, E. A.; Tarasova, N. I.; Gaitanaris, G. A.; Pavlakis, G. N.
  3. Biotechniques. 1998 24(3): 462 ff..
  1. 21.   Expression of a Murine Leukemia Virus Gag-Escherichia Coli Rnase Hi Fusion Polyprotein Significantly Inhibits Virus Spread
  2. Vanbrocklin, M.; Ferris, A. L.; Hughes, S. H.; Federspiel, M. J.
  3. Journal of Virology. 1997 71(4): 3312-3318.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel